VEILND (Video Endoscopic Inguinal Lymph Node Dissection) with Florescence Indocyanine Green (ICG): A Novel Technique to Identify the Sentinel Lymph Node in Men with ≥pT1G2 and cN0 Penile Cancer
Language English Country England, Great Britain Media electronic-ecollection
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
34803546
PubMed Central
PMC8570880
DOI
10.1155/2021/5575730
Knihovny.cz E-resources
- MeSH
- Indocyanine Green MeSH
- Humans MeSH
- Lymph Node Excision methods MeSH
- Lymph Nodes pathology MeSH
- Penile Neoplasms * diagnostic imaging pathology surgery MeSH
- Pilot Projects MeSH
- Sentinel Lymph Node * diagnostic imaging surgery MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Indocyanine Green MeSH
INTRODUCTION: In men with ≥pT1G2 cN0, penile cancer lymph node sampling is recommended with either (1) scintigraphically labelled Dynamic sentinel lymph node biopsy (DSLNB) or (2) modified inguinal lymph node dissection (MILND). Although DSLNB is a minimally invasive technique, the false negative rate can be about 10%, and a further operative procedure is required if positive. Open MILND is a diagnostic and therapeutic option but has a much higher morbidity. A potential compromise is the technique of LND-VEILND (video endoscopic inguinal LND) that can be combined with ICG florescence marking of sentinel lymph node (SLN). We present a pilot study of ICG-VEILND. The aim was to validate the applicability of a combination ICG marking of SLN in VEILND (to increase probability to excise SLN) and determine the optimal timing and dosage of ICG. MATERIALS AND METHODS: 15 patients with VEILND (24 groins) underwent ICG application with fluorescence near-infrared (NIR 803⟶830 nm) detection. ICG is applied subcutaneously adjacent to the penile cancer or residual stump of penis or suprapubic region (in a history of total penectomy: 5 cases). The dose of 1.25 mg (ICG) was applied in one case with invisible SLN, the dose of 2.5 mg in 1 mL in 8 cases, and 5 mg in the remaining 6 patients (10 groins). RESULTS: Failure of marking SLN with ICG occurred in 25.0% of cases (6/24): due to application of 1.25 mg ICG, extensive metastasis to SLN, in 4 cases, the cause was unknown (16.7%, 4/24). In the short follow-up period, no local recurrence was seen in the pN0 ICG group. CONCLUSION: Fluorescence infrared image with ICG dye increases the probability of removal of the SLN during VEILND. The dose of ICG is 2.5 (5) mg diluted in 1 ml and can be applied preoperatively even in the suprapubic region in men with a history of total penectomy, with an unexplainable failure of ICG marking in 16.7%.
See more in PubMed
Aydin A. M., Chakiryan N. H., Spiess P. E. Will dynamic sentinel lymph node biopsy become the new international standard for evaluating high-risk penile cancer in patients with clinically negative lymph nodes? European Urology. 2020;78(6):873–874. doi: 10.1016/j.eururo.2020.09.039. PubMed DOI
Hakenberg O. W., Compérat E. M., Minhas S., Necchi A., Protzel C., Watkin N. EAU guidelines on penile cancer: 2014 update. European Urology. 2015;67(1):142–150. doi: 10.1016/j.eururo.2014.10.017. PubMed DOI
Kroon B. K., Horenblas S., Estourgie S. H., Lont A. P., Valdés Olmos R. A., Nieweg O. E. How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. The Journal of Urology. 2004;171(6 Pt 1):2191–2194. doi: 10.1097/01.ju.0000124485.34430.15. PubMed DOI
O’Brien J. S., Perera M., Manning T., et al. Penile cancer: contemporary lymph node management. The Journal of Urology. 2017;197(6):1387–1395. doi: 10.1016/j.juro.2017.01.059. PubMed DOI
Nykodýmová Š., Travnicek I., Hes O., et al. The role of sentinel lymph node diagnostics in patients with penile carcinoma. European Urology Supplements. 2017;16(11) doi: 10.1016/s1569-9056(17)32070-5.e2933 DOI
Catalona W. J. Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results. The Journal of Urology. 1988;140(2):306–310. doi: 10.1016/s0022-5347(17)41589-8. PubMed DOI
Dell’Oglio P., de Vries H. M., Mazzone E., et al. Hybrid indocyanine green-99mTc-nanocolloid for single-photon emission computed tomography and combined radio- and fluorescence-guided sentinel node biopsy in penile cancer: results of 740 inguinal basins assessed at a single institution. European Urology. 2020;78(6):865–872. doi: 10.1016/j.eururo.2020.09.007. PubMed DOI
Bishoff J., Basler J., Teichman J., Thompson I. Endoscopic subcutaneous modified inguinal lymph node dissection (ESMIL) for squamous cell carcinoma of the penis. The Journal of Urology. 2003
Tobias-Machado M., Tavares A., Molina Jr W. R., Jr., Forseto Jr P. H., Jr., Juliano R. V., Wroclawski E. R. Video endoscopic inguinal lymphadenectomy (VEIL): minimally invasive resection of inguinal lymph nodes. International Brazilian Journal of Urology. 2006;32(3):316–321. doi: 10.1590/s1677-55382006000300012. PubMed DOI
Sotelo R., Sánchez-Salas R., Carmona O., et al. Endoscopic lymphadenectomy for penile carcinoma. Journal of Endourology. 2007;21(4):364–367. doi: 10.1089/end.2007.9971. PubMed DOI
Yadav S. S., Tomar V., Bhattar R., Jha A. K., Priyadarshi S. Video endoscopic inguinal lymphadenectomy vs open inguinal lymphadenectomy for carcinoma penis: expanding role and comparison of outcomes. Urology. 2018;113:79–84. doi: 10.1016/j.urology.2017.11.007. PubMed DOI
Ye Y.-L., Guo S.-J., Li Z.-S., et al. Radical videoscopic inguinal lymphadenectomies: a matched pair analysis. Journal of Endourology. 2018;32(10):955–960. doi: 10.1089/end.2018.0356. PubMed DOI
Russell C. M., Salami S. S., Niemann A., et al. Minimally invasive inguinal lymphadenectomy in the management of penile carcinoma. Urology. 2017;106:113–118. doi: 10.1016/j.urology.2017.04.022. PubMed DOI
Kumar V., Sethia K. K. Prospective study comparing video-endoscopic radical inguinal lymph node dissection (VEILND) with open radical ILND (OILND) for penile cancer over an 8-year period. BJU International. 2017;119(4):530–534. doi: 10.1111/bju.13660. PubMed DOI
Brouwer O. R., Buckle T., Vermeeren L., et al. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. Journal of Nuclear Medicine. 2012;53(7):1034–1040. doi: 10.2967/jnumed.112.103127. PubMed DOI
Brouwer O. R., van den Berg N. S., Mathéron H. M., et al. A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye. European Urology. 2014;65(3):600–609. doi: 10.1016/j.eururo.2013.11.014. PubMed DOI
Travniček I., Nykodýmová S., Pivovarčíková K., Michalová K., Ferda J., Mrázková P. 18-FDG PET-MRI in diagnostics of penile cancer, first experience. European Urology Supplements. 2017;16(11) doi: 10.1016/s1569-9056(17)32069-9.e2932 DOI
Cabanas R. M. An approach for the treatment of penile carcinoma. Cancer. 1977;39(2):456–466. doi: 10.1002/1097-0142(197702)39:2<456::aid-cncr2820390214>3.0.co;2-i. PubMed DOI
Wong J. H., Cagle L. A., Morton D. L. Lymphatic drainage of skin to a sentinel lymph node in a feline model. Annals of Surgery. 1991;214(5):637–641. doi: 10.1097/00000658-199111000-00015. PubMed DOI PMC
Morton D. L., Wen D. R., Wong J. H., Economou J. S., Cagle L. A., Storm F. K. Technical details of intraoperative lymphatic mapping for early stage melanoma. Archives of surgery. 1992;127(4):392–399. doi: 10.1001/archsurg.1992.01420040034005. PubMed DOI
Alex J. C., Krag D. N. Gamma-probe guided localization of lymph nodes. Surgical oncology. 1993;2(3):137–143. doi: 10.1016/0960-7404(93)90001-f. PubMed DOI
Horenblas S., Jansen L., Meinhardt W., Hoefnagel C. A., Jong D. D., Nieweg O. E. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. The Journal of Urology. 2000;163(1):100–104. doi: 10.1097/00005392-200001000-00025. PubMed DOI
Jakobsen J. K., Krarup K. P., Sommer P., et al. DaPeCa-1: diagnostic accuracy of sentinel lymph node biopsy in 222 patients with penile cancer at four tertiary referral centres - a national study from Denmark. BJU International. 2016;117(2):235–243. doi: 10.1111/bju.13127. PubMed DOI
Lam W., Alnajjar H. M., La-Touche S., et al. Dynamic sentinel lymph node biopsy in patients with invasive squamous cell carcinoma of the penis: a prospective study of the long-term outcome of 500 inguinal basins assessed at a single institution. European Urology. 2013;63(4):657–663. doi: 10.1016/j.eururo.2012.10.035. PubMed DOI
Motomura K., Inaji H., Komoike Y., Kasugai T., Noguchi S., Koyama H. Sentinel node biopsy guided by indocyanin green dye in breast cancer patients. Japanese Journal of Clinical Oncology. 1999;29(12):604–607. doi: 10.1093/jjco/29.12.604. PubMed DOI
KleinJan G. H., van Werkhoven E., van den Berg N. S., et al. The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes. European Journal of Nuclear Medicine and Molecular Imaging. 2018;45(11):1915–1925. doi: 10.1007/s00259-018-4028-x. PubMed DOI PMC
Crane L. M. A., Themelis G., Arts H. J. G., et al. Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results. Gynecologic Oncology. 2011;120(2):291–295. doi: 10.1016/j.ygyno.2010.10.009. PubMed DOI
Jewell E. L., Huang J. J., Abu-Rustum N. R., et al. Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies. Gynecologic Oncology. 2014;133(2):274–277. doi: 10.1016/j.ygyno.2014.02.028. PubMed DOI PMC
van der Poel H. G., Grivas N., van Leeuwen F. Comprehensive assessment of indocyanine green usage: one tracer, multiple urological applications. European urology focus. 2018;4(5):665–668. doi: 10.1016/j.euf.2018.08.017. PubMed DOI
Master V. A., Jafri S. M. A., Moses K. A., Ogan K., Kooby D. A., Delman K. A. Minimally invasive inguinal lymphadenectomy via endoscopic groin dissection: comprehensive assessment of immediate and long-term complications. The Journal of Urology. 2012;188(4):1176–1180. doi: 10.1016/j.juro.2012.06.038. PubMed DOI
Singh A., Jaipuria J., Goel A., et al. Comparing outcomes of robotic and open inguinal lymph node dissection in patients with carcinoma of the penis. The Journal of Urology. 2018;199(6):1518–1525. doi: 10.1016/j.juro.2017.12.061. PubMed DOI
Zhang M., Chen L., Zhang X., Ding J., Hua K. A comparative study of video endoscopic inguinal lymphadenectomy and conventional open inguinal lymphadenectomy for treating vulvar cancer. International Journal of Gynecological Cancer. 2017;27(9):1983–1989. doi: 10.1097/igc.0000000000001100. PubMed DOI